Four Corners Property Trust Acquires MOB in Tennessee

Four Corners Property Trust Acquires MOB in Tennessee

Four Corners Property Trust announced the acquisition of a medical office building (MOB) housing a Baptist Medical Group (BMG) primary care practice for $9.7 million. The transaction was priced at a 6.9% cap rate on rent as of the closing date and exclusive of transaction costs. The BMG property is located in a highly trafficked corridor in Tennessee and is corporate-operated under a long-term, triple-net lease with approximately 10 years of term remaining. BMG is the Mid-South’s largest integrated not-for-profit multispecialty physician practice, with more than 500 expert primary and specialty care doctors practicing throughout West Tennessee, North Mississippi and East Arkansas.... Read More »
Affidea Acquires Three Explora Group Clinics in Romania

Affidea Acquires Three Explora Group Clinics in Romania

Affidea, a Pan-European medical services provider, announced that it is expanding its presence in Romania with the acquisition of three Explora Group clinics. Explora Group is medical provider in the northern region of the country, offering advanced diagnostic imaging examinations and a comprehensive range of medical consultations. Affidea, formerly known as Euromedic, provides advanced diagnostic imaging, outpatient and cancer care services. Founded in 1991, Affidea’s network reaches 355 centers across 15 European countries, working with more than 11,200 professionals and seeing more than 11 million patients every year. “In response to the growing demand for medical services in the... Read More »
CBRE Announces Closing of Irving, Texas MOB

CBRE Announces Closing of Irving, Texas MOB

CBRE Group, Inc.’s U.S. Healthcare Capital Markets announced the closing of Baylor Irving MOB III, a medical office building (MOB) in Irving, Texas. Irving Hospital Authority is listed as the acquirer in the deal, and Madison Marquette is the seller.  The property is a Class A, 54,941-square-foot medical outpatient MOB positioned on the campus of the 293-bed Baylor Scott & White Medical Center – Irving, an acute care hospital. The recently developed property is currently 68% occupied by five tenants including an investment grade-credit health system, regional physician groups and private practices. Approximately 22% of the property is leased to HealthTexas Resource Network, a... Read More »
Sentrex Health Solutions Expands Services with Acquisition of PerCuro Clinical Research

Sentrex Health Solutions Expands Services with Acquisition of PerCuro Clinical Research

Sentrex Health Solutions announced the acquisition of PerCuro Clinical Research, a full-service specialty pharmacy and healthcare services provider based in Victoria, Canada.  PerCuro Clinical Research provides infusion services, clinical research and advanced nursing care. The company treats patients across several therapeutic areas, including inflammatory bowel disease, liver disease, neurology, dermatology and rare diseases. Established in 2003, PerCuro partners with healthcare providers on Vancouver Island, bringing healthcare services closer to physicians and patients.  Sentrex Health Solutions Inc. is a Canadian healthcare company based in Markham, Ontario. The company... Read More »
Novo Holdings Acquires Catalent for $16.5 Billion

Novo Holdings Acquires Catalent for $16.5 Billion

Novo Holdings A/S announced that it will acquire Catalent, Inc. in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis. The purchase price represents a premium of 16.5% to the closing price of Catalent’s common stock as of February 2, 2024, the last trading day prior to the announcement, and a 47.5% premium to the 60-day volume-weighted average price as of February 2, 2024.  Catalent is a contract development and manufacturing organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions. The company was formed in April 2007 when affiliates of the Blackstone Group acquired the core of the... Read More »
Arlington Capital Partners Announces Majority Investment in Afton Scientific

Arlington Capital Partners Announces Majority Investment in Afton Scientific

Arlington Capital Partners has announced a majority investment in Afton Scientific, a contract, development and manufacturing organization (CDMO) dedicated to sterile manufacturing of injectable pharmaceuticals. According to data captured in the LevinPro HC database, this acquisition marks the third CDMO transaction of the year. There were 21 CDMO transactions announced during 2023, and 39 during 2022. Based in Charlottesville, Virginia, Afton Scientific specializes in sterile injectable drug manufacturing as well as providing pre-sterilized vials and kits. The company performs aseptic fill-finish for products ranging from pre-clinical through commercial-scale manufacturing across various... Read More »